|
High Throughput Screening
remains to be one of the most
challenging and resource-intensive
steps in the drug discovery process,
with the end result depending on
proper balance of assays,
experimental design, and data
management.
The 2007
Assay Development & High-Throughput
Screening Conference aims to
present the latest technical
advances in cell-based and
biochemical assays and data
management along with examples of
the HTS applications in drug
discovery and development.
Critical Discussion Points
Include:
-
Cell Based Assays and HTS
Screenings
-
In vitro Assays and Screening
-
Applications in Drug Discovery
-
Data Collection and Management
| |
Keynote Speakers |
|
Peter Fuerst,
Ph.D.
Head Basel
Screening Operation
Novartis
Institutes for Biomedical
Research |
|
Jefferson Paslay, Ph.D.
Vice President, Screening Sciences
Wyeth Research |
**This conference takes place
concurrently with GTCbio’s
2nd
annual Protein Kinases in Drug
Discovery
conference. Register for one conference
and receive access to the
other!
|
UPCOMING EVENTS
3rd Stem Cell
Research & Therapeutics
March 22-23, 2007
San Diego, CA
Apoptosis in Drug Discovery
March 22-23, 2007
San Diego, CA
Enforcement and Litigation in
the Biotech and Pharmaceutical
Industry
April 19-20, 2007
San Francisco, CA
Register by
Mar. 19
for a 10% discount
2nd Protein Kinases in Drug
Discover
May 31 - June 1, 2007
Boston, MA
Register by Mar. 31
for a 20% discount
Targeted Designs for Clinical
Trials
July 19-20,
2007
Philadelphia, PA
2nd International Congress on
Immune Mediated Diseases
September 10-15,
2007
Moscow, Russia
Formulary and Reimbursement
Strategies For Effective Product
Planning
September 13-14,
2007
Philadelphia, PA
|
|
Presenting Faculty:
Matt Peters, AstraZeneca
Jonathan O'Connell, BMS
Jon Hawkinson, Elan Pharmaceuticals
Susan Pratt, Eli Lilly & Co.
Laura DeForge, Genentech Inc.
Anton Beletskii, General Electric
Jun Xian, Harvard University
Michael Weber, Merck & Co.
Peter Fuerst, Novartis
Steven Charlton, Novartis
Ron Johnson, NHGRI, NIH
Frank Stuhmeier, Pfizer, Inc.
Tara Stauffer, Pharmacopeia
Dominique Perrin, Serono
John Morin, Wyeth Research
Jefferson Pasley, Wyeth Research
For Speaker updates visit
www.gtcbio.com |
